生物伦理学导论:研究与临床实践的界限

Graciela Moya
{"title":"生物伦理学导论:研究与临床实践的界限","authors":"Graciela Moya","doi":"10.13107/jrs.2021.v01.i01.025","DOIUrl":null,"url":null,"abstract":"Numerous documents referred to the protection of people and especially those in vulnerable situations in biomedical research have been published. More than 70 years ago the “Nuremberg Code” (1947) laid the groundwork for regulations on human experimentation [4]. Three basic elements became the foundation for subsequent codes of ethics and research regulations: voluntary informed consent, favorable risk-benefit analysis, and the right to withdraw without repercussions [5]. A year later the “Universal Declaration of Human Rights” (1948) [6] was announced, expressing acknowledge of the inherent dignity and the equal and inalienable rights of all members of the human family. However, after the publication of both documents, numerous events in clinical research affected the life, rights, or well-being of participants [7]. These events led to the publication and updating of new recommendations, such as the “Declaration of Helsinki” of 1964, adopted by the World Medical Association, in an attempt to formulate a more specific international code of ethics [8]. As biomedical research efforts expanded, the Declaration has required nine subsequent updates, the last in 2013. The amended version of 1975 stated that research p ro jec t s s h o u l d b e su b m i tted to an independent research ethics committee for a p p ro b at i o n a n d s u p e r v i s i o n . T h i s committee must review the scientific quality of the research proposal and its conformity w ith nat ional law, being i ts g uiding framework for the protection, welfare, and safety of participants [9]. Therefore, these commissions have a central role in the r e s e a r c h p r o c e s s b y i m p r o v i n g t h e truthfulness and quality of clinical research [10]. The translation of new insights provided by basic biomedical research into innovative methods of diagnosis and therapy requires a strict safety and efficacy evaluation before it is being approved as a routine validated inter vention [2]. All these promising advances also posed some troubling ethical questions [3].","PeriodicalId":337981,"journal":{"name":"Journal of Regenerative Science","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Introduction to Bioethics: The Boundary Between Research and Clinical Practice\",\"authors\":\"Graciela Moya\",\"doi\":\"10.13107/jrs.2021.v01.i01.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Numerous documents referred to the protection of people and especially those in vulnerable situations in biomedical research have been published. More than 70 years ago the “Nuremberg Code” (1947) laid the groundwork for regulations on human experimentation [4]. Three basic elements became the foundation for subsequent codes of ethics and research regulations: voluntary informed consent, favorable risk-benefit analysis, and the right to withdraw without repercussions [5]. A year later the “Universal Declaration of Human Rights” (1948) [6] was announced, expressing acknowledge of the inherent dignity and the equal and inalienable rights of all members of the human family. However, after the publication of both documents, numerous events in clinical research affected the life, rights, or well-being of participants [7]. These events led to the publication and updating of new recommendations, such as the “Declaration of Helsinki” of 1964, adopted by the World Medical Association, in an attempt to formulate a more specific international code of ethics [8]. As biomedical research efforts expanded, the Declaration has required nine subsequent updates, the last in 2013. The amended version of 1975 stated that research p ro jec t s s h o u l d b e su b m i tted to an independent research ethics committee for a p p ro b at i o n a n d s u p e r v i s i o n . T h i s committee must review the scientific quality of the research proposal and its conformity w ith nat ional law, being i ts g uiding framework for the protection, welfare, and safety of participants [9]. Therefore, these commissions have a central role in the r e s e a r c h p r o c e s s b y i m p r o v i n g t h e truthfulness and quality of clinical research [10]. The translation of new insights provided by basic biomedical research into innovative methods of diagnosis and therapy requires a strict safety and efficacy evaluation before it is being approved as a routine validated inter vention [2]. All these promising advances also posed some troubling ethical questions [3].\",\"PeriodicalId\":337981,\"journal\":{\"name\":\"Journal of Regenerative Science\",\"volume\":\"34 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Regenerative Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.13107/jrs.2021.v01.i01.025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Regenerative Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13107/jrs.2021.v01.i01.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

已经发表了许多文件,其中提到在生物医学研究中保护人民,特别是那些处于弱势地位的人。70多年前的《纽伦堡法典》(1947)为人体实验的法规奠定了基础[4]。三个基本要素成为后来的伦理准则和研究法规的基础:自愿知情同意、有利的风险-收益分析和无后果退出的权利[5]。一年后,《世界人权宣言》(1948年)[6]宣布,承认人类大家庭所有成员的固有尊严以及平等和不可剥夺的权利。然而,在这两份文件发表后,临床研究中的许多事件影响了参与者的生活、权利或福祉[7]。这些事件导致了新的建议的出版和更新,如1964年世界医学协会通过的“赫尔辛基宣言”,试图制定更具体的国际道德准则[8]。随着生物医学研究工作的扩大,《宣言》随后进行了九次更新,最后一次是在2013年。1975年修订后的版本规定,研究不得进行任何形式的研究,但必须由一个独立的研究伦理委员会进行审查,因为该委员会在1975年对研究进行了审查,并在1975年对研究进行了审查。该委员会必须审查研究计划的科学质量及其是否符合国家法律,作为其对参与者的保护、福利和安全的指导框架[9]。因此,这些委员会在临床研究的真实性和质量方面发挥着核心作用,在临床研究的真实性和质量方面发挥着重要作用[10]。将基础生物医学研究提供的新见解转化为创新的诊断和治疗方法,需要在被批准为常规有效干预措施之前进行严格的安全性和有效性评估[2]。所有这些有希望的进展也提出了一些令人不安的伦理问题[3]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Introduction to Bioethics: The Boundary Between Research and Clinical Practice
Numerous documents referred to the protection of people and especially those in vulnerable situations in biomedical research have been published. More than 70 years ago the “Nuremberg Code” (1947) laid the groundwork for regulations on human experimentation [4]. Three basic elements became the foundation for subsequent codes of ethics and research regulations: voluntary informed consent, favorable risk-benefit analysis, and the right to withdraw without repercussions [5]. A year later the “Universal Declaration of Human Rights” (1948) [6] was announced, expressing acknowledge of the inherent dignity and the equal and inalienable rights of all members of the human family. However, after the publication of both documents, numerous events in clinical research affected the life, rights, or well-being of participants [7]. These events led to the publication and updating of new recommendations, such as the “Declaration of Helsinki” of 1964, adopted by the World Medical Association, in an attempt to formulate a more specific international code of ethics [8]. As biomedical research efforts expanded, the Declaration has required nine subsequent updates, the last in 2013. The amended version of 1975 stated that research p ro jec t s s h o u l d b e su b m i tted to an independent research ethics committee for a p p ro b at i o n a n d s u p e r v i s i o n . T h i s committee must review the scientific quality of the research proposal and its conformity w ith nat ional law, being i ts g uiding framework for the protection, welfare, and safety of participants [9]. Therefore, these commissions have a central role in the r e s e a r c h p r o c e s s b y i m p r o v i n g t h e truthfulness and quality of clinical research [10]. The translation of new insights provided by basic biomedical research into innovative methods of diagnosis and therapy requires a strict safety and efficacy evaluation before it is being approved as a routine validated inter vention [2]. All these promising advances also posed some troubling ethical questions [3].
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信